Abstract
Protein microarray is a highly sensitive tool for antibody detection in serum. Monitoring of patients’ antibody titers to specific antigens is increasingly employed in the diagnosis of several conditions, ranging from infectious diseases, allergies, autoimmune diseases, and cancer. In this protocol, we present a detailed method for enzymatic generation of disease-specific O-glycopeptides and how to monitor the antibody response to these in serum using microarray technology.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kingsmore SF (2006) Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat Rev Drug Discov 5(4):310–320
Robinson WH (2006) Antigen arrays for antibody profiling. Curr Opin Chem Biol 10(1):67–72
Chevaliez S, Pawlotsky JM (2008) Diagnosis and management of chronic viral hepatitis: antigens, antibodies and viral genomes. Best Pract Res Clin Gastroenterol 22(6):1031–1048
Murdoch DR et al (2012) Laboratory methods for determining pneumonia etiology in children. Clin Infect Dis 54(Suppl 2):S146–S152
Fall BI et al (2003) Microarrays for the screening of allergen-specific IgE in human serum. Anal Chem 75(3):556–562
Ferrer M et al (2009) Molecular diagnosis in allergology: application of the microarray technique. J Investig Allergol Clin Immunol 19(Suppl 1):19–24
Leslie D, Lipsky P, Notkins AL (2001) Autoantibodies as predictors of disease. J Clin Invest 108(10):1417–1422
Routsias JG, Tzioufas AG, Moutsopoulos HM (2004) The clinical value of intracellular autoantigens B-cell epitopes in systemic rheumatic diseases. Clin Chim Acta 340(1–2):1–25
Wu J et al (2017) The roles and applications of autoantibodies in progression, diagnosis, treatment and prognosis of human malignant tumours. Autoimmun Rev 16(12):1270–1281
Tainsky MA (2009) Genomic and proteomic biomarkers for cancer: a multitude of opportunities. Biochim Biophys Acta 1796(2):176–193
Anderson KS, LaBaer J (2005) The sentinel within: exploiting the immune system for cancer biomarkers. J Proteome Res 4(4):1123–1133
Tarp MA, Clausen H (2008) Mucin-type O-glycosylation and its potential use in drug and vaccine development. Biochim Biophys Acta 1780(3):546–563
Pedersen JW et al (2010) Seromic profiling of colorectal cancer patients with novel glycopeptide microarray. Int J Cancer 128(8):1860–1871
Wandall HH et al (2010) Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes. Cancer Res 70(4):1306–1313
Clo E et al (2012) Characterization of the viral O-glycopeptidome: a novel tool of relevance for vaccine design and serodiagnosis. J Virol 86(11):6268–6278
Pedersen JW et al (2014) Cancer-associated autoantibodies to MUC1 and MUC4—a blinded case-control study of colorectal cancer in UK collaborative trial of ovarian cancer screening. Int J Cancer 134(9):2180–2188
Sahin U et al (1995) Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci U S A 92(25):11810–11813
Pereira-Faca SR et al (2007) Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer. Cancer Res 67(24):12000–12006
Stockert E et al (1998) A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med 187(8):1349–1354
Mintz PJ et al (2003) Fingerprinting the circulating repertoire of antibodies from cancer patients. Nat Biotechnol 21(1):57–63
Anderson KS et al (2008) Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer. J Proteome Res 7(4):1490–1499
Ramachandran N et al (2004) Self-assembling protein microarrays. Science 305(5680):86–90
Schietinger A et al (2006) A mutant chaperone converts a wild-type protein into a tumor-specific antigen. Science 314(5797):304–308
Chui D et al (2001) Genetic remodeling of protein glycosylation in vivo induces autoimmune disease. Proc Natl Acad Sci U S A 98(3):1142–1147
Opdenakker G et al (2006) Remnant epitopes, autoimmunity and glycosylation. Biochim Biophys Acta 1760(4):610–615
Axford JS et al (1992) Changes in normal glycosylation mechanisms in autoimmune rheumatic disease. J Clin Invest 89(3):1021–1031
Delves PJ (1998) The role of glycosylation in autoimmune disease. Autoimmunity 27(4):239–253
Olofsson S, Blomberg J (1977) Studies on glycopeptides of Herpes simplex virus infected cells. Arch Virol 55(4):293–304
Brennan PJ et al (1976) Metabolism of galactose in herpes simplex virus-infected cells. Virology 69(1):216–228
Karthikeyan K et al (2016) A contra capture protein array platform for studying post-translationally modified (PTM) auto-antigenomes. Mol Cell Proteomics 15(7):2324–2337
Herzner H et al (2000) Synthesis of glycopeptides containing carbohydrate and peptide recognition motifs. Chem Rev 100(12):4495–4538
Blixt O, Clo E (2013) Synthesis of O-glycopeptides and construction of glycopeptide microarrays. Methods Mol Biol 1047:201–214
Taylor-Papadimitriou J et al (2002) MUC1 and the immunobiology of cancer. J Mammary Gland Biol Neoplasia 7(2):209–221
Rughetti A et al (2005) Recombinant tumor-associated MUC1 glycoprotein impairs the differentiation and function of dendritic cells. J Immunol 174(12):7764–7772
Wandall HH et al (1997) Substrate specificities of three members of the human UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3. J Biol Chem 272(38):23503–23514
Bennett EP et al (1998) Cloning of a human UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat. J Biol Chem 273(46):30472–30481
Ikehara Y et al (1999) Cloning and expression of a human gene encoding an N-acetylgalactosamine-alpha2,6-sialyltransferase (ST6GalNAc I): a candidate for synthesis of cancer-associated sialyl-Tn antigens. Glycobiology 9(11):1213–1224
Iwai T et al (2002) Molecular cloning and characterization of a novel UDP-GlcNAc:GalNAc-peptide beta1,3-N-acetylglucosaminyltransferase (beta 3Gn-T6), an enzyme synthesizing the core 3 structure of O-glycans. J Biol Chem 277(15):12802–12809
Mirgorodskaya E et al (1999) Partial vapor-phase hydrolysis of peptide bonds: a method for mass spectrometric determination of O-glycosylated sites in glycopeptides. Anal Biochem 269(1):54–65
Pedersen JW et al (2011) Lectin domains of polypeptide GalNAc transferases exhibit glycopeptide binding specificity. J Biol Chem 286(37):32684–32696
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Pedersen, J.W., Nøstdal, A., Wandall, H.H. (2019). Multiplexed Detection of Autoantibodies to Glycopeptides Using Microarray. In: Fulton, K., Twine, S. (eds) Immunoproteomics. Methods in Molecular Biology, vol 2024. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9597-4_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9597-4_12
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9596-7
Online ISBN: 978-1-4939-9597-4
eBook Packages: Springer Protocols